Analysts’ Viewpoint
The global acute kidney injury treatment market development is driven by the increase in geriatric patient population, surge in incidence of kidney damage cases, and rise in prevalence of chronic diseases such as hypertension and diabetes across the globe. Growth in number of dialysis centers, increase in critical care admissions, presence of large geriatric population, and government initiatives to improve healthcare sector are the key market movers.
Leading companies are focusing on the development of immunologic-based therapies for acute kidney injury and chronic kidney disease (CKD). Furthermore, significant investment by startups in research & development activities in order to launch novel treatment for acute kidney injury is transforming the business landscape.
Acute kidney injury (AKI) is a sudden episode of kidney failure/damage that can range from minor loss of kidney functions to complete kidney failure. Diarrhea, feeling sick or being sick, dehydration, drowsiness, and confusion are some of the common symptoms of acute kidney injuries.
Treatment for kidney injuries primarily depends on the cause and extent of the injury. Experimental treatments for the management of AKIs primarily comprise vasoactive peptides, growth-factors, endothelin inhibitors, adhesion molecules, and bio-artificial kidneys. Aminophylline has also been used experimentally for prophylaxis, specifically against renal failure (RF).
Request a sample to get extensive insights into the Acute Kidney Injury Treatment Market
The geriatric population has increased in the past few years, especially in developed countries such as the U.S., Japan, and most countries in Western Europe. These countries have high geriatric population vis-à-vis their developing counterparts. This can be ascribed to the improvement in health care infrastructure, favorable reimbursement policies, and advancements in health care facilities. Access to multiple diagnostic and treatment services has improved, specifically in developed countries. This has increased the life expectancy of the population.
Studies indicate that a majority (60% to 70%) of the elderly population is susceptible to acute kidney injury. Increase in geriatric population leads to high rate of ailments. This, in turn, is likely to augment the demand for acute kidney injury medications across the globe in the near future.
Around 13.3 million people across the world are estimated to be affected by acute kidney injury. The patient population is expected to rise substantially in the next few decades. Increase in incidence rate of acute kidney injury is creating a significant socioeconomic impact across the globe.
According to an independent research, multiple system organ failure (MSOF) and other comorbidities contribute to high mortality rate among intensive care unit (ICU) patients. However, the mortality rate of AKI stands at 50% to 80% in ICU patients. Acute kidney injury (AKI) often occurs in intensive care units (ICUs), thus leading to high expenditure along with adverse clinical outcomes.
AKI is primarily associated with incomplete kidney recovery and increase in mortality and cost. This is likely to lead to a surge in demand for effective acute kidney failure treatment, which is projected to accelerate acute kidney injury treatment market progress.
Request a custom report on Acute Kidney Injury Treatment Market
In terms of treatment, the dialysis segment accounted for major market share in 2021. Dialysis facilitates the survival of critically ill patients with AKIs. The total number of dialysis service centers has increased across the globe. This is anticipated to drive the dialysis segment during the forecast period.
According to the United States Renal Data system (USRDS), the U.S. had more than 7,500 dialysis centers in 2021. Governments of developing countries are setting up new dialysis centers and improving the existing ones. In November 2022, Southlake Biotech, an innovative biotech-firm, announced that it will receive US$ 33.0 Mn in financing to advance its portfolio of kidney disease treatments.
Pre-renal acute kidney injuries account for 55% to 65% of cases with acute kidney injury (AKIs). Introduction of novel drugs and increase in investment in research and innovation are likely to augment the pre-renal acute kidney injury segment during the forecast period.
North America accounted for around 43.0% share of the global industry in 2021. Increase in geriatric population, rise in acute kidney injury patient pool, promising clinical pipeline, and development of advanced & efficient products are fueling the North America market expansion. Rise in number of key players; increase in acquisitions, mergers, and collaborations; government approval for new products; and surge in adoption of advanced products are boosting business outlook in the region.
Asia Pacific is projected to be a rapidly growing region for AKI treatment during the forecast period. Increase in geriatric population; rise in prevalence of chronic diseases, which are high risk factors for acute kidney injury; growth in urbanization; and surge in critical care admissions are boosting the region's market statistics. Government initiatives in the healthcare sector, increase in investment in R&D activities, and rise in presence of global players are fueling the demand for AKI treatment in Asia Pacific.
The acute kidney injury treatment market is highly consolidated, with the presence of small number of dominant players. Companies are engaging in strategic alliances to increase revenue and market share. Players are also adopting strategies such as product line expansion and acquisitions & mergers to broaden their business footprint.
Major players in the acute kidney injury treatment sector are Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem.
The acute kidney injury treatment industry report profiles leading players based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 1.5 Bn |
|
Forecast Value in 2031 |
More than US$ 3.0 Bn |
|
Growth Rate (CAGR) for 2022-2031 |
7.5% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The industry was valued at US$ 1.5 Bn in 2021.
It is projected to reach more than US$ 3.0 Bn by 2031.
The global market is anticipated to grow at a CAGR of 7.5% from 2022 to 2031.
Increase in incidence of acute kidney injury, surge in number of dialysis centers, large geriatric population, and effective governmental initiatives taken to improve healthcare sector.
North America is expected to account for major share during the forecast period.
Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Acute Kidney Injury Treatment Market: Market Snapshot
4. Market Overview
4.1. Global Acute Kidney Injury Treatment Market: Overview
4.2. Global Acute Kidney Injury Treatment Market: Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Acute Kidney Injury Treatment Market Revenue Projection, 2017–2031
4.5. Global Acute Kidney Injury Treatment Market Outlook
5. Market Outlook
5.1. Acute Kidney Injury Epidemiology: Overview
5.2. Key Merger and Acquisitions
5.3. Pipeline Analysis
5.4. CCOVID-19 Impact on Industry
6. Global Acute Kidney Injury Treatment Market Analysis, by Treatment
6.1. Key Findings
6.2. Introduction
6.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Treatment
6.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Treatment
6.4.1. Dialysis
6.4.2. Supportive Care
6.5. Global Acute Kidney Injury Treatment Market Analysis, by Treatment
7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, by Type
7.1. Key Findings
7.2. Introduction
7.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Type
7.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Type
7.4.1. Pre-renal Acute Kidney Injury
7.4.2. Intrinsic Renal Acute Kidney Injury
7.4.3. Post-renal Acute Kidney Injury
7.5. Global Acute Kidney Injury Treatment Market Analysis, by Type
8. Global Acute Kidney Injury Treatment Market Analysis, by End-user
8.1. Key Findings
8.2. Introduction
8.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by End-user
8.4. Global Acute Kidney Injury Treatment Market Value Forecast, by End-user
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Others
8.5. Global Acute Kidney Injury Treatment Market Analysis, by End-user
9. Global Acute Kidney Injury Treatment Market Analysis, by Region
9.1. Global Acute Kidney Injury Treatment Market Scenario, by Country
9.2. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Region
9.3. Global Acute Kidney Injury Treatment Market Value Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Acute Kidney Injury Treatment Market Analysis
10.1. Key Findings
10.2. North America Acute Kidney Injury Treatment Market Overview
10.3. North America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country
10.4. North America Acute Kidney Injury Treatment Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
10.6. North America Acute Kidney Injury Treatment Market Forecast, by Treatment
10.6.1. Dialysis
10.6.2. Supportive Care
10.7. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
10.8. North America Acute Kidney Injury Treatment Market Forecast, by Type
10.8.1. Pre-renal Acute Kidney Injury
10.8.2. Intrinsic Renal Acute Kidney Injury
10.8.3. Post-renal Acute Kidney Injury
10.9. North America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
10.10. North America Acute Kidney Injury Treatment Market Forecast, by End-user
10.10.1. Hospitals
10.10.2. Ambulatory surgical centers
10.10.3. Others
10.11. North America Acute Kidney Injury Treatment Market Attractiveness Analysis
11. Europe Acute Kidney Injury Treatment Market Analysis
11.1. Key Findings
11.2. Europe Acute Kidney Injury Treatment Market Overview
11.3. Europe Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.4. Europe Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
11.6. Europe Acute Kidney Injury Treatment Market Forecast, by Treatment
11.6.1. Dialysis
11.6.2. Supportive Care
11.7. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type
11.8. Europe Acute Kidney Injury Treatment Market Forecast, by Type
11.8.1. Pre-renal Acute Kidney Injury
11.8.2. Intrinsic Renal Acute Kidney Injury
11.8.3. Post-renal Acute Kidney Injury
11.9. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
11.10. Europe Acute Kidney Injury Treatment Market Forecast, by End-user
11.10.1. Hospitals
11.10.2. Ambulatory Surgical Centers
11.10.3. Others
11.11. Europe Acute Kidney Injury Treatment Market Attractiveness Analysis
12. Asia Pacific Acute Kidney Injury Treatment Market Analysis
12.1. Key Findings
12.2. Asia Pacific Acute Kidney Injury Treatment Market Overview
12.3. Asia Pacific Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.4. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
12.4.1. China
12.4.2. India
12.4.3. Japan
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
12.6. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Treatment
12.6.1. Dialysis
12.6.2. Supportive Care
12.7. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type
12.8. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Type
12.8.1. Pre-renal Acute Kidney Injury
12.8.2. Intrinsic Renal Acute Kidney Injury
12.8.3. Post-renal Acute Kidney Injury
12.9. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
12.10. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by End-user
12.10.1. Hospitals
12.10.2. Ambulatory Surgical Centers
12.10.3. Others
12.11. Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis
13. Latin America Acute Kidney Injury Treatment Market Analysis
13.1. Key Findings
13.2. Latin America Acute Kidney Injury Treatment Market Overview
13.3. Latin America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.4. Latin America Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America
13.5. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
13.6. Latin America Acute Kidney Injury Treatment Market Forecast, by Treatment
13.6.1. Dialysis
13.6.2. Supportive Care
13.7. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
13.8. Latin America Acute Kidney Injury Treatment Market Forecast, by Type
13.8.1. Pre-renal Acute Kidney Injury
13.8.2. Intrinsic Renal Acute Kidney Injury
13.8.3. Post-renal Acute Kidney Injury
13.9. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
13.10. Latin America Acute Kidney Injury Treatment Market Forecast, by End-user
13.10.1. Hospitals
13.10.2. Ambulatory Surgical Centers
13.10.3. Others
13.11. Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis
14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Acute Kidney Injury Treatment Market Overview
14.3. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region
14.4. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East and Africa
14.5. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
14.6. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Treatment
14.6.1. Dialysis
14.6.2. Supportive Care
14.7. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type
14.8. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Type
14.8.1. Pre-renal Acute Kidney Injury
14.8.2. Intrinsic Renal Acute Kidney Injury
14.8.3. Post-renal Acute Kidney Injury
14.9. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
14.10. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by End-user
14.10.1. Hospitals
14.10.2. Ambulatory Surgical Centers
14.10.3. Others
14.11. Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis
15. Competition Landscape
15.1. Acute Kidney Injury Treatment Market Share Analysis, by Company, 2021
15.2. Competition Matrix
15.3. Company Profiles
15.3.1. Angion Biomedica Corp
15.3.1.1. Company Details
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. AM-Pharma
15.3.2.1. Company Details
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Quark Pharmaceuticals, Inc.
15.3.3.1. Company Details
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. Baxter International, Inc.
15.3.4.1. Company Details
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Fresenius Medical Care AG & Co. KGaA
15.3.5.1. Company Details
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. LG Chem
15.3.6.1. Company Details
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Asahi Kasei Medical Co., Ltd.
15.3.7.1. Company Details
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. B. Braun Melsungen AG
15.3.8.1. Company Details
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
List of Tables
Table 01: Acute Kidney Injury Treatment Market Merger and Acquisition Deals
Table 02: Acute Kidney Injury Treatment Market Merger and Acquisition Deals
Table 03: AKI Pipeline Analysis
Table 04: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031
Table 05: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 06: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 08: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 09: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 10: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031
Table 11: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 14: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031
Table 15: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 18: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031
Table 19: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 22: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031
Table 23: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 25: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 26: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031
Table 27: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Distribution, by Region, 2021 and 2031
Figure 02: Global Acute Kidney Injury Treatment Market Revenue Projection (US$ Mn), 2017–2031
Figure 03: Global Acute Kidney Injury Treatment Market Value Share, by Treatment, 2021
Figure 04: Global Acute Kidney Injury Treatment Market Value Share, by Region, 2021
Figure 05: Global Acute Kidney Injury Treatment Market Value Share, by Type, 2021
Figure 06: Global Acute Kidney Injury Treatment Market Value Share, by End-user, 2021
Figure 07: Global Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 08: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 09: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Dialysis, 2017–2031
Figure 10: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Supportive Care, 2017–2031
Figure 11: Global Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031
Figure 12: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031
Figure 13: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Pre-renal Acute Kidney Injury, 2017–2031
Figure 14: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Intrinsic Renal Acute Kidney Injury, 2017–2031
Figure 15: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Post-renal Acute Kidney Injury, 2017–2031
Figure 16: Global Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031
Figure 17: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 18: Global Acute Kidney Injury Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2031
Figure 19: Global Acute Kidney Injury Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2017–2031
Figure 20: Global Acute Kidney Injury Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2031
Figure 21: Global Acute Kidney Injury Treatment Market Value Share, by Region, 2021 and 2031
Figure 22: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by Region, 2022–2031
Figure 23: North America Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 24: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Country, 2021 and 2031
Figure 25: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country, 2022–2031
Figure 26: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031
Figure 27: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031
Figure 28: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 29: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 30: North America Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031
Figure 31: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 32: Europe Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 33: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 34: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 35: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031
Figure 36: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031
Figure 37: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 38: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 39: Europe Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031
Figure 40: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 41: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 42: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 43: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 44: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031
Figure 45: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031
Figure 46: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 47: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 48: Asia Pacific Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031
Figure 49: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 50: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 51: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 52: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 53: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031
Figure 54: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031
Figure 55: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 56: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 57: Latin America Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031
Figure 58: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 59: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 60: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 61: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 62: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031
Figure 63: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031
Figure 64: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031
Figure 65: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031
Figure 66: Middle East & Africa Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031
Figure 67: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031
Figure 68: Baxter International, Inc. Breakdown of Net Sales, by Region, 2018
Figure 69: Baxter International, Inc. R&D Intensity and Sales & Marketing Intensity - Company Level (US$ Mn), 2019–2021
Figure 70: Baxter International, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2019–2021
Figure 71: Baxter International, Inc. Breakdown of Net Sales, by Business Segment, 2021
Figure 72: Fresenius Medical Care AG & Co. KGaA Breakdown of Net Sales, by Region, 2021
Figure 73: Fresenius Medical Care AG & Co. KGaA R&D Intensity and Sales & Marketing Intensity - Company Level (US$ Mn), 2019–2021
Figure 74: Fresenius Medical Care AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2019–2021
Figure 75: Fresenius Medical Care AG & Co. KGaA Breakdown of Net Sales, by Business Segment (Health Care Services), 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Acute Kidney Injury Treatment Market
*86 figures and 60 tables includes